Aliases & Classifications for Hemarthrosis

About this section

Aliases & Descriptions for Hemarthrosis:

Name: Hemarthrosis 11 50 39 13 68
Hemarthrosis Involving Pelvic Region and Thigh 11
Haemarthrosis of the Pelvic Region and Thigh 11
Hemarthrosis of the Pelvic Region and Thigh 11
Hemarthrosis Involving Shoulder Region 11
Hemarthrosis of the Ankle and/or Foot 11
Hemarthrosis Involving Ankle and Foot 11
Haemarthrosis of the Ankle and Foot 11
Hemarthrosis of the Shoulder Region 11
Hemarthrosis of the Ankle and Foot 11
Hemarthrosis of Ankle and/or Foot 11
Hemarthrosis Involving Upper Arm 11
Hemarthrosis Involving Lower Leg 11
 
Hemarthrosis of Shoulder Region 11
Haemarthrosis of Shoulder Joint 11
Hemarthrosis Involving Forearm 11
Hemarthrosis of the Upper Arm 11
Hemarthrosis of the Lower Leg 11
Hemarthrosis of the Forearm 11
Hemarthrosis Involving Hand 11
Hemarthrosis of Upper Arm 11
Hemarthrosis of Lower Leg 11
Hemarthrosis of the Hand 11
Hemarthrosis of Shoulder 11
Hemarthrosis of Forearm 11
Hemarthrosis of Hand 11

Classifications:



External Ids:

Disease Ontology11 DOID:801
ICD1030 M25.0
ICD9CM32 719.1, 719.10
MeSH39 D006395

Summaries for Hemarthrosis

About this section
Wikipedia:71 Hemarthrosis (or haemarthrosis, plural h(a)emarthroses) is a bleeding into joint spaces. It is a common... more...

MalaCards based summary: Hemarthrosis, also known as hemarthrosis involving pelvic region and thigh, is related to factor x deficiency and factor v deficiency, and has symptoms including nail bed hemorrhage, stiffness of joint, not elsewhere classified in icd10cm and mucosal haemorrhage. An important gene associated with Hemarthrosis is F8 (Coagulation Factor VIII), and among its related pathways are Transcription_Role of VDR in regulation of genes involved in osteoporosis and FGF signaling pathway. Affiliated tissues include bone, b cells and monocytes, and related mouse phenotypes are cardiovascular system and homeostasis/metabolism.

Related Diseases for Hemarthrosis

About this section

Diseases related to Hemarthrosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 88)
idRelated DiseaseScoreTop Affiliating Genes
1factor x deficiency32.1F7, F9
2factor v deficiency29.4F10, F7, F8, F9, VWF
3type 2n von willebrand disease29.3F8, VWF
4myocardial infarction28.5F10, F7, F8, VWF
5afibrinogenemia, congenital10.8
6factor vii deficiency10.8
7high anorectal malformation10.3F8, F9
8acquired fructose intolerance10.3F8, F9
9diabetic autonomic neuropathy10.2F8, F9
10hemophilia10.2
11transient cerebral ischemia10.1F7, F9
12esophagus leiomyosarcoma10.1F7, F9
13papillary adenocarcinoma10.0BGLAP, SPP1
14brill-zinsser disease10.0BGLAP, F7
15tyrobp-related polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy10.0F8, VWF
16tyrosine hydroxylase-deficient dopa-responsive dystonia10.0F8, VWF
17synovitis10.0
18familial spastic paralysis10.0F8, VWF
19malignant type ab thymoma10.0F8, VWF
20nail disorder, nonsyndromic congenital, 19.9BGLAP, SPP1
21von willibrand disease, type 39.9F8, VWF
22tympanosclerosis9.9F8, VWF
23peripheral osteosarcoma9.9BGLAP, SPP1
24wfs1-related disorders9.9F8, VWF
25arthritis9.9
26leydig cell tumor9.9F8, VWF
27extraskeletal chondroma9.9F8, F9
28physical disorder9.9BGLAP, SPP1
29vertebrobasilar insufficiency9.9F7, SPP1
30facioscapulohumeral muscular dystrophy 19.9F7, F8, F9
31van maldergem syndrome 29.9F8, VWF
32scurvy9.9
33hemophilia a9.8
34acute myocardial infarction9.8
35thrombasthenia9.8
36aneurysm9.8
37adams-oliver syndrome 59.7SPP1, VWF
38glanzmann thrombasthenia9.7
39lipoma9.7
40osteoarthritis9.7
41pigmented villonodular synovitis9.7
42purpura9.7
43arthropathy9.7
44villonodular synovitis9.7
45acquired hemophilia9.7
46secondary central precocious puberty9.7F10, F8, VWF
47microcytic anemia9.7F7, VWF
48pregnancy loss, recurrent 29.7F10, F8, VWF
49ceroid lipofuscinosis, neuronal, 69.6SPP1, VWF
50allain-babin-demarquez syndrome9.6F8, F9, VWF

Graphical network of the top 20 diseases related to Hemarthrosis:



Diseases related to hemarthrosis

Symptoms & Phenotypes for Hemarthrosis

About this section

UMLS symptoms related to Hemarthrosis:


nail bed hemorrhage, stiffness of joint, not elsewhere classified in icd10cm, mucosal haemorrhage, traumatic hematuria, cullen's sign, hyperextension, other symptoms referable to joint, joint swelling, metatarsalgia, hemoptysis, arthralgia

MGI Mouse Phenotypes related to Hemarthrosis according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053858.7F10, F7, F9, SPP1, VWF
2MP:00053767.6F10, F7, F8, F9, SPP1, VWF

Drugs & Therapeutics for Hemarthrosis

About this section

Drugs for Hemarthrosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 47)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
RopivacaineapprovedPhase 474184057-95-471273, 175805
Synonyms:
(2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide
(2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride
(S)-(−)-1-propyl-2',6'-pipecoloxylidide
(S)-ropivacaine
84057-95-4
98717-15-8
AC1L41QM
AC1L41QN
BIDD:GT0203
C07532
C17H26N2O.HCl
CHEBI:8890
CHEMBL1077896
CID175804
CID175805
CPD000469137
D08490
I14-176
L-N-n-propylpipecolic acid-2,6-xylidide
LS-113954
 
MLS001401363
MolPort-003-983-292
NCGC00164597-01
Naropin
Naropin (TN)
ROPIVACAINE HCl
Ropivacaina
Ropivacaina [INN-Spanish]
Ropivacaina [Spanish]
Ropivacaine
Ropivacaine [INN]
Ropivacaine hydrochloride
Ropivacaine monohydrochloride
Ropivacainum
Ropivacainum [INN-Latin]
S-Ropivacaine
SAM001246524
SMR000469137
ST51051452
ropivacaine monohydrochloride,
ropivacaine monohydrochloride, (S)-isomer
2
Triamcinoloneapproved, vet_approvedPhase 4482124-94-731307
Synonyms:
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione
11.Beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11β,16α,17α,21-tetrahydroxy-9α-fluoro-1,4-pregnadiene-3,20-dione
124-94-7
4-08-00-03629 (Beilstein Handbook Reference)
83474-03-7
9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-16-alpha-hydroxyprednisolone
9-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahy
9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-d
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-16alpha-hydroxyprednisolone
9α-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-16α-hydroxyprednisolone
AC-2072
AC1L1LDH
AC1Q5HJC
Adcortyl
Aristocort
Aristocort A
Aristocort Tablets
Aristogel
Aristospan
Azmacort
BPBio1_000154
BRD-K77554836-001-03-3
BRN 2341955
BSPBio_000140
Bio-0662
C21H27FO6
CHEMBL1451
CID31307
CL 19823
Celeste
Cinolone
Cinolone-T
D00385
D014221
DB00620
Delphicort
EINECS 204-718-7
EU-0101179
Fluoxiprednisolone
Fluoxyprednisolone
Flutex
Fougera
HMS1568G22
HMS2090D12
HSDB 3194
Kenacort
Kenacort (TN)
Kenacort-A
Kenacort-AG
Kenacort-Ag
Kenalog
Kenalog in Orabase
Kenalog-10
Kenalog-40
Kenalog-H
LS-698
Ledercort
Lopac0_001179
 
MLS000028542
MLS001066543
MLS002695935
MolPort-002-528-981
Mycolog
NCGC00021580-03
NCGC00021580-04
NCGC00021580-05
NCGC00021580-06
NCGC00021580-07
NCI60_000750
NSC 13397
NSC13397
Nasacort
Nasacort Aq
Nasacort Hfa
Omcilon
Omicilon
Oracort
Oralone
Orion
Polcortolon
Pregna-1,4-diene-3,20-dio
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI)
Prestwick0_000120
Prestwick1_000120
Prestwick2_000120
Prestwick3_000120
Prestwick_438
Rodinolone
S1933_Selleck
SK-Triamcinolone
SMP1_000300
SMR000058333
SPBio_002079
Sk-Triamcinolone
T6376_SIGMA
TRIAMCINOLONE (SEE ALSO TRIAMCINOLONE ACETONIDE (76-25-5) AND TRIAMCINOLONE DIACETATE (67-78-7))
Tiamcinolonum
Tiamcinolonum [INN-Latin]
Tri-Nasal
Triacet
Triacort
Triam-Tablinen
Triamcet
Triamcinalone
Triamcinlon
Triamcinolon
Triamcinolona
Triamcinolona [INN-Spanish]
Triamcinolone (JP15/USP/INN)
Triamcinolone [USAN:INN:BAN:JAN]
Triamcinolone acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Triamcinolonum
Triamcinolonum [INN]
Triatex
Tricortale
Triderm
Trilone
Tristoject
Trymex
UNII-1ZK20VI6TY
Vetalog
Volon
Volon A
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ
ZINC03882036
droxypregna-1,4-diene-3,20-dione
ione
nchembio.2007.53-comp7
triamcinolone
3
Hyaluronic acidapproved, vet_approvedPhase 44399004-61-953477741, 24759
Synonyms:
Hyaluronan
Hyaluronate
Hyaluronic acid
Hylartil
Hyruan Plus
Luronit
 
Macronan
Mucoitin
Nutra-HAF
Q 5AQ
Sepracoat
Sepragel Sinus
Sofast
Synvisc
4
BenzocaineapprovedPhase 4, Phase 318921994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Caswell No. 430A
Chloraseptic
D001566
D00552
DB01086
Dermoplast
Diet Ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
 
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Formate, Benzocaine
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
MLS001331704
MLS002153970
Methanesulfonate, Benzocaine
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Norcain
Norcaine
Norcainum
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orthesin
Otocain
Outgro
Parathesin
Parathesin (TN)
Parathesine
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
5
Bevacizumabapproved, investigationalPhase 41968216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
6tannic acidapproved, NutraceuticalPhase 4, Phase 31892
7CoagulantsPhase 4, Phase 3, Phase 21428
8Factor VIIIPhase 4, Phase 3, Phase 2304
9HylanPhase 445
10ViscosupplementsPhase 4364
11Triamcinolone diacetatePhase 4482
12Protective AgentsPhase 47190
13Adjuvants, ImmunologicPhase 42484
14triamcinolone acetonidePhase 4482
15Triamcinolone hexacetonidePhase 4482
16Angiogenesis InhibitorsPhase 44143
17Angiogenesis Modulating AgentsPhase 44072
18ImmunoglobulinsPhase 36045
19AntibodiesPhase 36045
20Immunoglobulin Fc FragmentsPhase 341
21HemostaticsPhase 21359
22
Povidone-iodineapproved15525655-41-8
Synonyms:
 
Betadine
23
Chlorhexidineapproved, vet_approved47255-56-19552079, 2713
Synonyms:
1,1 inverted exclamation marka-Hexamethylenebis[5-(4-chlorophenyl)biguanide]
1,1'-Hexamethylene bis(5-(P-chlorophenyl)biguanide)
1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide)
1,1'-Hexamethylenebis(5-(p-chlorophenyl)biguanide)
1,1'-Hexamethylenebis[5-(4-chlorophenyl)biguanide
1,6-Bis(5-(p-chlorophenyl)biguandino)hexane
1,6-Bis(p-chlorophenyldiguanido)hexane
1,6-Di(4'-chlorophenyldiguanido)hexane
1,6-Di(N-p-chlorophenyldiguanido)hexane
24798_FLUKA
282227_ALDRICH
348031_ALDRICH
4-12-00-01201 (Beilstein Handbook Reference)
55-56-1
AB00053427
AB1003159
AVAGARD
BPBio1_000272
BRN 2826432
BSPBio_000246
BSPBio_001977
C06902
C22H30Cl2N10
CAS-55-56-1
CCRIS 9230
CHEBI:3614
CHEMBL790
CID9552079
Chlorhexidin
Chlorhexidin [Czech]
Chlorhexidine
Chlorhexidine (INN)
Chlorhexidine Base
Chlorhexidine [INN:BAN]
Chlorhexidine gluconate
Chlorhexidinum
Chlorhexidinum [INN-Latin]
Cloresidina
Cloresidina [DCIT]
Clorhexidina
Clorhexidina [INN-Spanish]
D07668
DB00878
Decanoylacetaldehyde Sodium Sulfide
Dentisept [veterinary]
Dentisept [veterinary] (TN)
DivK1c_000761
EINECS 200-238-7
Fimeil
HMS1568M08
HSDB 7196
Hexadol
Hibiclens
Hibispray
Hibistat
I06-0621
I14-0050
IDI1_000761
 
KBio1_000761
KBio2_000717
KBio2_003285
KBio2_005853
KBio3_001197
KBioGR_000774
KBioSS_000717
LS-43917
Lisium (*Dihydrochloride*)
MK-412A
MLS001332387
MLS001332388
MLS002154209
Merfen-incolore
Merfen-incolore (TN)
MolPort-002-541-741
N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)]
N,N''''-hexane-1,6-diylbis[N'-(4-chlorophenyl)(imidodicarbonimidic diamide)]
N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradeca- nediimidamide
N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
N,N'-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
NCGC00016246-01
NCGC00091025-01
NCGC00091025-02
NINDS_000761
NSC526936
Nolvasan
Nolvasan (*Diacetate*)
Novalsan
Oro-Clense
Peridex
Periogard
Prestwick0_000143
Prestwick1_000143
Prestwick2_000143
Prestwick3_000143
Prestwick_53
QTL1_000020
Rotersept
SMR000857146
SPBio_000210
SPBio_002185
STK089248
STOCK1S-18831
Savloclens
Savlon babycare
Sebidin A
Sodium Houttuyfonamide
Soretol
Spectrum2_000135
Spectrum3_000339
Spectrum4_000277
Spectrum5_001322
Spectrum_000237
Sterido
Sterilon
Superspray
Tubulicid
UNII-R4KO0DY52L
chlorhexidine
24
Epinephrineapproved, vet_approved93351-43-45816
Synonyms:
(-)-(R)-Epinephrine
(-)-3,4-Dihydroxy-a-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol
(-)-3,4-Dihydroxy-alpha-[2-(methylamino)ethyl]benzyl alcohol
(-)-3,4-dihydroxy-a-[(methylamino)methyl]-Benzyl alcohol
(-)-3,4-dihydroxy-alpha-[(methylamino)methyl]-Benzyl alcohol
(-)-Adrenalin
(-)-Adrenaline
(-)-Epinephrine
(-)-R-Epinephrine
(R)-(-)-Adnephrine
(R)-(-)-Adrenaline
(R)-(-)-Epinephrine
(R)-(-)-Epirenamine
(R)-(−)-adrenaline
(R)-4-[1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
(R)-4-[1-hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
(R)-Adrenaline
(R)-Epinephrine
(−)-adrenaline
02252_FLUKA
1-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
1-Adrenalin
1-Epinephrine
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol
4-(1-hydroxy-2-methylamino-ethyl)benzene-1,2-diol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-Benzenediol
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol
4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
51-43-4
51-43-4 (FREE BASE)
51028-73-0
A0173
AC-13188
AC1L1L7B
ADR ADRENALINE
ADROP
AI3-19015
Adnephrine
Adrenal
Adrenalin
Adrenalin (TN)
Adrenalin in Oil
Adrenalin-Medihaler
Adrenalina
Adrenalina [DCIT]
Adrenaline
Adrenaline (JP15)
Adrenaline/Epinephrine
Adrenalinum
Adrenamine
Adrenan
Adrenapax
Adrenasol
Adrenatrate
Adrenine
Adrenodis
Adrenohorma
Adrenosan
Adrenutol
Adrin
Adrine
Ana-Guard
Ana-Kit
Antiasthmatique
Asmatane Mist
Asthma meter mist
Asthma-nefrin
Asthmahaler Mist
Asthmanefrin
Astmahalin
Astminhal
BIDD:GT0119
Balmadren
Bernarenin
Biorenine
Bosmin
Brevirenin
Bronkaid
Bronkaid Mist
Bronkaid Suspension Mist
Bupivacaine Hcl and Epinephrine
C00788
CCRIS 4812
CHEBI:28918
CHEMBL679
CID5816
Chelafrin
Citanest Forte
Corisol
D-Epifrin
D-Epinephrine
D00095
DB00668
Drenamist
Dylephrin
Dyspne-Inhal
E4250_SIGMA
EINECS 200-098-7
EPI E Z PEN JR
EPIPEN E Z PEN
EPIPEN JR
Epi EZ Pen Jr
Epifrin
Epiglaufrin
Epinefrin
Epinefrin [Czech]
Epinefrina
Epinefrina [INN-Spanish]
Epinephran
Epinephrin
Epinephrine
Epinephrine (USP)
Epinephrine (USP/INN)
Epinephrine [USAN:INN:JAN]
Epinephrine hydrochloride
Epinephrinum
Epinephrinum [INN-Latin]
Epipen
Epipen (TN)
Epipen Auto-Injector
Epipen EZ Pen
Epipen Jr.
Epipen Jr. Auto-Injector
Epirenamine
Epirenan
Epirenin
Epitrate
Eppy
Esphygmogenina
Exadrin
 
Glaucon
Glaucosan
Glauposine
Glycirenan
HSCI1_000215
HSDB 4289
Haemostasin
Haemostatin
Hektalin
Hemisine
Hemostasin
Hemostatin
Hypernephrin
Hyporenin
IOP
Intranefrin
Iontocaine
Isoptoepinal
Kidoline
L-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
L-Adrenaline
L-Adrenaline Base
L-Epinehphrine
L-Epinephrine
L-Epirenamine
L-Methylaminoethanolcatechol
L-epinephrine
LS-156
Levo-Methylaminoethanolcatechol
Levoadrenaline
Levoepinephrine
Levorenen
Levorenin
Levorenine
Levoreninum
Lopac-E-4642
Lyodrin
Lyophrin
Medihaler-Epi
Metanephrin
Methylaminoethanolcatechol
Methylarterenol
Micronefrin
Micronephrine
MolPort-002-051-368
Mucidrina
Myosthenine
Mytrate
NCGC00015417-01
NCGC00142615-01
NCGC00142615-03
NCGC00142615-04
NCGC00142615-05
NCGC00142615-06
NCGC00142615-07
NSC 62786
NSC62786
Nephridine
Nieraline
PDSP1_001120
PDSP2_001104
Paranephrin
Primatene
Primatene Mist
R-(-)-Epinephrine
R-Adrenaline
RCRA waste no. P042
Racemic Epinephrine
Racepinephrine
Rcra waste number P042
Renagladin
Renaglandin
Renaglandulin
Renaleptine
Renalina
Renoform
Renostypricin
Renostypticin
Renostyptin
SMP1_000227
ST069368
SUS-PHRINE SULFITE-FREE
Scurenaline
Septocaine
Simplene
Sindrenina
Soladren
Sphygmogenin
Stryptirenal
Styptirenal
Supracapsulin
Supradin
Supranefran
Supranephrane
Supranephrine
Supranol
Suprarenaline
Suprarenin
Suprel
Surenine
Surrenine
Sus-Phrine
Sus-phrine
Susphrine
Sympathin I
Takamina
Takamine
Tokamina
Tonogen
Twinject
Twinject 0.15
Twinject 0.3
Twinject 0.30
UNII-YKH834O4BH
Vaponefrin
Vasoconstrictine
Vasoconstrictor
Vasodrine
Vasoton
Vasotonin
adrenaline
bmse000316
d-Adrenaline
epinephrine
l-1-(3,4-Dihydroxyphenyl)-2-methylaminoethanol
l-Adrenalin
l-Adrenaline
l-Epinephine
l-Epinephrine (synthetic)
l-Epirenamine
l-Methylaminoethanolcatechol
levoepinephrine
nchembio747-comp9
25
Bupivacaineapproved, investigational11312180-92-9, 38396-39-32474
Synonyms:
( inverted exclamation markA)-bupivacaine
(+-)-Bupivacaine
(1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
(RS)-bupivacaine
(±)-bupivacaine
1-Butyl-2',6'-pipecoloxylidide
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
15233-43-9
2180-92-9
38396-39-3
AB00053674
AC-2096
AC1L1DRE
AC1Q5LX4
AH 250
AKOS001637202
AR-1A0242
Anekain
BPBio1_000298
BRD-A01636364-003-05-2
BSPBio_000270
BSPBio_002607
Bio-0886
Bloqueina
Bucaine
Bucaine (TN)
Bupivacaina
Bupivacaina [INN-Spanish]
Bupivacaine (INN)
Bupivacaine Carbonate
Bupivacaine HCL
Bupivacaine HCL KIT
Bupivacaine Monohydrochloride, Monohydrate
Bupivacaine [INN:BAN]
Bupivacainum
Bupivacainum [INN-Latin]
Bupivan
C07529
C18H28N2O
CBupivacaine
CHEBI:3215
CHEMBL1098
CID2474
Carbostesin
D07552
DB00297
DL-Bupivacaine
DUR-843
 
DepoBupivacaine
DivK1c_000758
EINECS 218-553-3
EINECS 253-911-2
HMS2090F12
IDI1_000758
KBio1_000758
KBio2_002004
KBio2_004572
KBio2_007140
KBio3_001827
KBioGR_001516
KBioSS_002004
KST-1A4609
L000695
LAC-43
LS-109841
LS-2222
MLS001361336
Marcaina
Marcaine
Marcaine HCL
Marcaine Spinal
MolPort-004-955-820
NCGC00178579-01
NCGC00178579-02
NINDS_000758
NSC119660
Prestwick0_000305
Prestwick1_000305
Prestwick2_000305
Prestwick3_000305
SMR000058218
SPBio_001558
SPBio_002489
Sensorcaine
Sensorcaine-MPF
Sensorcaine-MPF Spinal
Spectrum2_001589
Spectrum3_000974
Spectrum4_001098
Spectrum5_001483
Spectrum_001524
Transdur-Bupivacaine
UNII-Y8335394RO
Win 11318
Win 11318 HCl
bupivacaine
cBupivacaine
dl-1-Butyl-2',6'-pipecoloxylidide
racemic bupivacaine
26Chlorhexidine gluconate472
27Chelating Agents1365
28Thrombin288
29Narcotics3486
30Mydriatics763
31Epinephryl borate933
32Neurotransmitter Agents17734
33Peripheral Nervous System Agents22776
34Vasoconstrictor Agents2027
35Respiratory System Agents4818
36Racepinephrine933
37Adrenergic Agents5140
38Central Nervous System Depressants12806
39Anesthetics9001
40Adrenergic beta-Agonists1640
41Adrenergic alpha-Agonists1625
42Anesthetics, Local3272
43Anti-Asthmatic Agents3369
44Bronchodilator Agents2856
45Autonomic Agents9774
46Adrenergic Agonists2877
47Soy BeanNutraceutical535

Interventional clinical trials:

(show top 50)    (show all 73)
idNameStatusNCT IDPhase
1Subclinical Joint Bleeding in Irish Adults With Severe Haemophilia A on Personalised Prophylaxis RegimensUnknown statusNCT02314325Phase 4
2Trial of NovoSeven® in Haemophilia - Joint BleedsCompletedNCT00108797Phase 4
3High Dose of Activated Recombinant Human Factor VII for Treatment of Mild/Moderate Joint Bleeds in Haemophilia Patients With InhibitorsCompletedNCT00571584Phase 4
4Viscosupplementation in Patients With Hemophilic ArthropathyCompletedNCT01748201Phase 4
5Russian Kogenate Pediatric StudyCompletedNCT00632814Phase 4
6BAY14-2222 Prophylaxis and Joint Function Improvement (Adults)CompletedNCT00586521Phase 4
7Impact of Conservative Treatment by Custom-made Orthoses in Patients With Haemophilic Ankle ArthropathyCompletedNCT00638001Phase 4
8Canadian Hemophilia Prophylaxis StudyCompletedNCT01085344Phase 4
9Prophylaxis Versus on Demand Treatment for Children With Hemophilia ACompletedNCT01810666Phase 4
10Efficacy and Cost Effectiveness of Pharmacokinetic Dosing in Haemophilia ACompletedNCT02697370Phase 4
11Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment RegimensCompletedNCT00927667Phase 4
12Intra-articular Bevacizumab for Recurrent Hemarthroses at Target Joints With Chronic Hemophilic SynovitisRecruitingNCT02060305Phase 4
13Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A."RecruitingNCT02581969Phase 4
14A Clinical Phenotype Based Individualized Prophylaxis in Chinese Hemophilia A ChildrenRecruitingNCT02999308Phase 4
15Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia BCompletedNCT00364182Phase 3
16Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia ACompletedNCT01458106Phase 3
17Study of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in Previously Treated Pediatric Participants With Hemophilia BCompletedNCT01440946Phase 3
18Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Subjects With Severe Hemophilia ACompletedNCT01181128Phase 3
19Study to Determine the Safety and Efficacy of rFIXFc in Untreated Males With Severe Hemophilia BRecruitingNCT02234310Phase 3
20A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors (HAVEN 3)RecruitingNCT02847637Phase 3
21A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus No Prophylaxis in Hemophilia A Patients With Inhibitors (HAVEN 1)RecruitingNCT02622321Phase 3
22An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Untreated Males With Severe Hemophilia ARecruitingNCT02234323Phase 3
23BAX 855 PK-Guided DosingRecruitingNCT02585960Phase 3
24Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia BActive, not recruitingNCT01425723Phase 3
25A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia AActive, not recruitingNCT01580293Phase 2, Phase 3
26Long-Term Safety and Efficacy of rFVIIIFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia AEnrolling by invitationNCT01454739Phase 3
27Early Prophylaxis Immunologic Challenge (EPIC) StudyTerminatedNCT01376700Phase 3
28rFVIIa Prophylaxis in Children With Hemophilia A and InhibitorsUnknown statusNCT01105546Phase 2
29Haemophilia Patients With Inhibitors Being Treated for Acute Joint BleedsCompletedNCT00486278Phase 2
30Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIIICompletedNCT00245245Phase 2
31A Proof-of-Concept Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Hemophilic ArthropathyRecruitingNCT02994147Phase 2
32BAY79-4980 Compared to rFVIII-FS in Previously Treated Patients With Severe Hemophilia ATerminatedNCT00623727Phase 2
33Individualized Prophylaxis for Severe Hemophilia A ChildrenUnknown statusNCT02116855
34Biomechanical Determinants and Patterns Associated to the Pathophysiological Cascade of Ankle Arthropathy in Children With Haemophilia: Non-invasive In-vivo Measurement of Foot Joints in Children With Haemophilia During Gait.Unknown statusNCT02229331
35Musculoskeletal Function in HemophiliaUnknown statusNCT00324493
36Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and InhibitorsCompletedNCT01234545
37The FEIBA NovoSeven Comparative StudyCompletedNCT00166309
38Efficacy of Peroperative Suction Drain Usage in Arthroscopic Knee SurgeryCompletedNCT02752581
39Manual Therapy in Haemophilic Arthropathy of the KneeCompletedNCT02198014
40Physiotherapy in the Haemophilic Arthropathy of the Elbow.CompletedNCT02198040
41The Von Willebrand Disease (VWD) International Prophylaxis StudyCompletedNCT00557908
42Multidisciplinary Evaluation of Patients With HemophiliaCompletedNCT02198430
43Gait Evaluation in Haemophiliac PatientsCompletedNCT00824798
44Educational Physiotherapy in HaemophiliaCompletedNCT02825706
45Bilateral Deficit Phenomenon in Patients With Haemophilic ArthropathyCompletedNCT02165462
46Platelet-Rich Plasma Intra-Articular Injection in Treating Hemophilic ArthropathyCompletedNCT02601170
47Prophylaxis Versus On-demand Therapy Through Economic ReportCompletedNCT01159587
48Impact of Pain on Functional Impairment and Quality of Life in Adults With HemophiliaCompletedNCT01988532
49Aspiration for Pain Relief Following Ankle FractureCompletedNCT01484535
50The Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding LogsCompletedNCT00212459

Search NIH Clinical Center for Hemarthrosis


Cochrane evidence based reviews: hemarthrosis

Genetic Tests for Hemarthrosis

About this section

Anatomical Context for Hemarthrosis

About this section

MalaCards organs/tissues related to Hemarthrosis:

36
Bone, B cells, Monocytes, Myeloid, Skeletal muscle

Publications for Hemarthrosis

About this section

Articles related to Hemarthrosis:

(show top 50)    (show all 223)
idTitleAuthorsYear
1
Endovascular Management of Recurrent Spontaneous Hemarthrosis After Arthroplasty. (27882429)
2017
2
Abnormal joint and bone wound healing in hemophilia mice is improved by extending factor IX activity after hemarthrosis. (28039188)
2016
3
Technically Successful Geniculate Artery Embolization Does Not Equate Clinical Success for Treatment of Recurrent Knee Hemarthrosis after Knee Surgery. (26806692)
2016
4
Geniculate Artery Embolization for Management of Recurrent Hemarthrosis: A Single-Center Experience. (27338503)
2016
5
Reducing Intra-articular Hemarthrosis After Arthroscopic ACL Reconstruction: Response. (26929179)
2016
6
Epidemiology of intra- and peri-articular structural injuries in traumatic knee joint hemarthrosis - data from 1145 consecutive knees with subacute MRI. (27374877)
2016
7
Acute Hemarthrosis of the Knee Caused by Arteriovenous Malformation. (27231206)
2016
8
Reducing Intra-articular Hemarthrosis After Arthroscopic ACL Reconstruction: Letter to the Editor. (26929178)
2016
9
Effects of hemarthrosis on cartilage and synovium in rabbits. (26936196)
2016
10
Spontaneous Recurrent Hemarthrosis of the Knee: A Report of Two Cases with a Source of Bleeding Detected during Arthroscopic Surgery of the Knee Joint. (27703824)
2016
11
Reducing Intra-articular Hemarthrosis After Arthroscopic Anterior Cruciate Ligament Reconstruction by the Administration of Intravenous Tranexamic Acid: A Prospective, Randomized Controlled Trial. (26337246)
2015
12
Recurrent Hemarthrosis Following Knee Arthroplasty Treated with Arterial Embolization. (26092252)
2015
13
LASER versus electromagnetic field in treatment of hemarthrosis in children with hemophilia. (26306883)
2015
14
Joint Aspiration for Acute Hemarthrosis in Children Receiving Factor VIII Prophylaxis for Severe Hemophilia: 11-year Safety Data. (25729030)
2015
15
Geniculate artery embolization for recurrent postarthroplasty hemarthrosis of the knee. (27398122)
2015
16
Spontaneous hemarthrosis following fibrinolytic therapy for acute myocardial infarction: a case report and literature review. (25417208)
2014
17
Occult Intra-articular Knee Injuries in Children With Hemarthrosis. (24753236)
2014
18
Anticoagulant-induced hemarthrosis presenting as anterior shoulder dislocation. (25043625)
2014
19
Spontaneous hemarthrosis in combined Glanzmann thrombasthenia and type 2N von Willebrand disease. (24418945)
2014
20
Recurrent hemarthrosis : an unusual cause. (23680622)
2013
21
Antiplasmin, but not amiloride, prevents synovitis and cartilage damage following hemarthrosis in hemophilic mice. (24283895)
2013
22
Geniculate artery embolization in the management of spontaneous recurrent hemarthrosis of the knee: case series. (23433418)
2013
23
Selective arterial embolization with gelatin particles for refractory knee hemarthrosis. (23846552)
2013
24
A case of selective arterial embolization for recurrent hemarthrosis after total knee arthroplasty. (22237971)
2013
25
Hemarthrosis in hemophilic mice results in alterations in M1-M2 monocyte/macrophage polarization. (24252538)
2013
26
Recurrent hemarthrosis after total knee arthroplasty caused by the impingement of a remnant lateral meniscus: A case report. (24231622)
2013
27
Hemophilic chronic synovitis: therapy of hemarthrosis using endovascular embolization of knee and elbow arteries. (23150120)
2013
28
A case of bilateral hemarthrosis due to pseudoaneurysms in a patient on anticoagulation therapy. (23669803)
2013
29
Spontaneous recurrent hemarthrosis of the knee joint in the elderly: a report of two cases. (21607723)
2012
30
Intra-articular nodular fasciitis of the knee: a rare cause of recurrent hemarthrosis. (21431289)
2012
31
Transarterial embolization for the management of hemarthrosis of the knee. (22154590)
2012
32
Knee hemarthrosis after arthroscopic surgery in an athlete with low factor XIII activity. (23031577)
2012
33
MRI findings in adolescent patients with acute traumatic knee hemarthrosis. (23147616)
2012
34
Cartilage and bone markers and inflammatory cytokines are increased in synovial fluid in the acute phase of knee injury (hemarthrosis)--a cross-sectional analysis. (22874525)
2012
35
Hemarthrosis in a patient on warfarin receiving ceftaroline: a case report and brief review of cephalosporin interactions with warfarin. (22764328)
2012
36
A rare case of meniscal hematoma with hemarthrosis of the knee: a case report. (21938355)
2011
37
Recurrent hemarthrosis in a boy with synovial hemangioma: a case report. (21088622)
2011
38
Recurrent hemarthrosis after unicompartmental knee arthroplasty. (21902161)
2011
39
Trauma resulting in hemarthrosis and long medial collateral ligament desmitis of the tarsocrural joint in a horse. (22043073)
2011
40
Magnetic resonance angiography in the management of recurrent hemarthrosis after total knee arthroplasty. (21397454)
2011
41
Does the source of hemarthrosis influence posttraumatic joint contracture and biomechanical properties of the joint? (21420211)
2011
42
Glanzmann thrombasthenia detected because of knee hemarthrosis: a case report. (20736850)
2010
43
Synovial hypertrophy causing recurrent hemarthrosis after total knee replacement. (20812578)
2010
44
Late recurrent hemarthrosis following knee arthroplasty associated with epithelioid angiosarcoma of bone. (19945286)
2010
45
Spontaneous recurrent hemarthrosis of the knee joint in elderly patients with osteoarthritis: an infrequent presentation of synovial lipoma arborescens. (20526580)
2010
46
Recurrent hemarthrosis in a hemophilic patient after revision total knee arthroplasty. (20954656)
2010
47
Recurrent hemarthrosis after total knee arthroplasty. (20076944)
2010
48
Angiographic findings and therapeutic embolization of late hemarthrosis after total joint arthroplasty. (18773205)
2009
49
Acute traumatic hemarthrosis of the adult's knee--a diagnostic options in arthroscopic era. Literature review. (19133435)
2008
50
Isolation and characterization of connective tissue progenitor cells derived from human fracture-induced hemarthrosis in vitro. (17763429)
2008

Variations for Hemarthrosis

About this section

Expression for genes affiliated with Hemarthrosis

About this section
Search GEO for disease gene expression data for Hemarthrosis.

Pathways for genes affiliated with Hemarthrosis

About this section

Pathways related to Hemarthrosis according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.0BGLAP, SPP1
29.0BGLAP, SPP1
39.0BGLAP, SPP1
49.0BGLAP, SPP1
5
Show member pathways
8.7F10, F7, F8, F9
68.3BGLAP, F10, F7, F9
7
Show member pathways
8.3BGLAP, F10, F7, F9
8
Show member pathways
8.2F10, F7, F8, F9, VWF
9
Show member pathways
8.2F10, F7, F8, F9, VWF
10
Show member pathways
7.9BGLAP, F10, F7, F8, F9

GO Terms for genes affiliated with Hemarthrosis

About this section

Cellular components related to Hemarthrosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cell projectionGO:00429959.8BGLAP, SPP1
2platelet alpha granule lumenGO:00310939.6F8, VWF
3Golgi lumenGO:00057968.7BGLAP, F10, F7, F9
4endoplasmic reticulum lumenGO:00057888.7BGLAP, F10, F7, F8, F9
5extracellular spaceGO:00056158.3BGLAP, F7, F8, F9, SPP1
6extracellular regionGO:00055767.5BGLAP, F10, F7, F8, F9, SPP1

Biological processes related to Hemarthrosis according to GeneCards Suite gene sharing:

(show all 12)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of protein kinase B signalingGO:005189710.1F10, F7
2blood coagulation, extrinsic pathwayGO:00075989.8F10, F7, F9
3response to estrogenGO:00436279.7BGLAP, F7
4response to nutrient levelsGO:00316679.6BGLAP, F7
5response to vitamin KGO:00325719.5BGLAP, F7
6response to vitamin DGO:00332809.4BGLAP, SPP1
7blood coagulation, intrinsic pathwayGO:00075979.4F10, F8, F9, VWF
8cell adhesionGO:00071559.2BGLAP, SPP1, VWF
9blood coagulationGO:00075968.9F10, F7, F8, F9, VWF
10peptidyl-glutamic acid carboxylationGO:00171878.9BGLAP, F10, F7, F9
11ER to Golgi vesicle-mediated transportGO:00068888.5BGLAP, F10, F7, F8, F9
12signal peptide processingGO:00064658.3BGLAP, F10, F7, F9

Molecular functions related to Hemarthrosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1endopeptidase activityGO:000417510.2F7, F9
2glycoprotein bindingGO:000194810.0F7, VWF
3calcium ion bindingGO:00055098.9BGLAP, F10, F7, F9
4serine-type endopeptidase activityGO:00042528.7F10, F7, F8, F9

Sources for Hemarthrosis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet